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337 3D Echocardiographic Location of Implantable Device Leads and Mechanism
of Associated Tricuspid Regurgitation
Anuj Mediratta, Karima Addetia, Megan Yamat, Joshua D. Moss, Hemal M. Nayak,
Martin C. Burke, Lynn Weinert, Francesco Maffessanti, Valluvan Jeevanandam,
Victor Mor-Avi, Roberto M. Lang
Vini: Implantable device-leads have been reported to cause tricuspid regurgitation (TR) yet few
data are available on how to minimize this complication.
Vidi: In the present cohort study of 121 patients, 3D-echocardiography was used to correlate
device lead placement with the degree of TR. Of 47% of patients who had leaﬂet impingement,
septal and posterior leaﬂet impingement was the most common and there was more TR in this
group compared with those without leaﬂet impingement.
Vici: This study raises the possibility that 3D echocardiography guided lead placement may
minimize device-lead induced TR. The clinical impact of this intervention needs prospective
study.
348 EDITORIAL COMMENT 3D Imaging of Device Leads: “Taking the Lead With 3D”Allan L. Klein, Christine L. Jellis
351 Impaired Resting Myocardial Annular Velocities Are Independently Associated
With Mental Stress–Induced Ischemia in Coronary Heart Disease
Mads Ersbøll, Fawaz Al Enezi, Zainab Samad, Brenda Sedberry, Stephen H. Boyle,
ChristopherO’Connor,Wei Jiang,Eric J.Velazquez, onbehalf of theREMITInvestigators
Vini: Mental stress induced myocardial ischemia (MSIMI), which portends adverse outcomes,
may be present in 45% to 60% of patients with coronary artery disease. The diagnosis of this
entity is usually inferred and conﬁrmation using imaging tests has been challenging.
Vidi: In this sub-study of patients screened for the REMIT trial of escitalopram, the investigators
sought whether impaired resting tissue Doppler annular velocities might be associated with
increased propensity for MSIMI. The authors report that the eas-index [e’/(a’  s’)], an integrated
measure of systolic and diastolic myocardial function, is independently associated with MSIMI.
Vici: A more effective means of identifying MSIMI may facilitate speciﬁc treatments of this entity,
and outcome beneﬁt should be sought.
362 EDITORIAL COMMENT A Microvascular-Myocardial Diastolic Dysfunctional State
and Risk for Mental Stress Ischemia: A Revised Concept of Ischemia During Daily Life
Carl J. Pepine, John W. Petersen, C. Noel Bairey Merz(continued on page A-8)
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A-8366 Prediction of High-Risk Plaque Development and Plaque Progression With the
Carotid Atherosclerosis Score
Dongxiang Xu, Daniel S. Hippe, Hunter R. Underhill, Minako Oikawa-Wakayama,
Li Dong, Kiyofumi Yamada, Chun Yuan, Thomas S. Hatsukami
Vini: Asymptomatic carotid stenosis continues to give clinicians equipoise with respect to
management and timing of intervention. Plaque characteristics that predict progression or
clinical ischemic events remain poorly understood.
Vidi: The current prospective study tested the predictive value of a carotid atherosclerosis score
(CAS) for development of high-risk plaque features, such as new intraplaque hemorrhage (IPH)
and disrupted luminal surface (DLS). Amongst 120 asymptomatic subjects with 50% to 79%
stenosis, a signiﬁcant increasing relationship was observed between baseline CAS and incident
DLS and plaque progression during follow-up.
Vici: Although these ﬁndings need validation in larger cohorts, this study suggests that the use
of CAS may improve risk stratiﬁcation beyond luminal stenosis and identify subgroups that may
beneﬁt from early carotid intervention.
374 Additional Value of Transluminal Attenuation Gradient in CT Angiography
to Predict Hemodynamic Signiﬁcance of Coronary Artery Stenosis
Wynand J. Stuijfzand, Ibrahim Danad, Pieter G. Raijmakers, C. Bogdan Marcu,
Martijn W. Heymans, Cornelis C. van Kuijk, Albert C. van Rossum, Koen Nieman,
James K. Min, Jonathon Leipsic, Niels van Royen, Paul Knaapen
Vini: Transluminal attenuation gradient (TAG), the contrast opaciﬁcation gradient along the
artery, in coronary computed tomography angiography (CTA), can add functional information,
but it is not clear if this adds clinical valve over morphology alone.
Vidi: 85 patients with intermediate probability of coronary artery disease (CAD) were studied
prospectively. Using FFR as the gold standard, TAG even after correction for nonuniform contrast
delivery and calciﬁcation, did not provide major incremental value over coronary CTA alone.
Vici: While this small study is not deﬁnitive, it highlights the difﬁculties in deriving functional
information that is clinically additive to the morphology obtained from a CTA in the diagnosis of
ﬂow limiting CAD.(continued on page A-9)
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A-9387 Diagnostic Value of PET-Measured Longitudinal Flow Gradient for the
Identiﬁcation of Coronary Artery Disease
Ines Valenta, Alessandra Quercioli, Thomas H. Schindler
Vini: Although PET-determined reductions in myocardial ﬂow reserve (MFR) are increasingly
applied to identify epicardial lesions in coronary artery disease (CAD), it may be seen as
a suboptimal approach due to the nonspeciﬁc origin of decreases in MFR.
Vidi: Based on a vessel-based analysis, the sensitivity, speciﬁcity, and diagnostic accuracy of the
Dlongitudinal myocardial blood ﬂow (MBF) gradient in the identiﬁcation of epicardial lesions
50% were higher than those for MFR, respectively. Combining both parameters resulted in an
optimal sensitivity of 100% and intermediate speciﬁcity of 75% in the 24 patients studied.
Vici: The combined evaluation of a Dlongitudinal MBF gradient and MFR may evolve as a new
promising analytic approach to further optimize the identiﬁcation of CAD lesions. How this novel
methodology will compare to CT-based angiography or other imaging modalities for assessing
epicardial coronary stenoses 50% warrants further study.
397 Clinical Outcome of Nonculprit Plaque Ruptures in Patients With Acute Coronary
Syndrome in the PROSPECT Study
Yong Xie, Gary S. Mintz, Junqing Yang, Hiroshi Doi, Andrés Iñiguez,
George D. Dangas, Patrick W. Serruys, John A. McPherson, Bertil Wennerblom,
Ke Xu, Giora Weisz, Gregg W. Stone, Akiko Maehara
Vini: Multifocal plaque ruptures, involving nonculprit plaques, are not uncommon in patients
with acute coronary syndrome (ACS) but their morphology and behavior are not well described.
Vidi: The present study uses the 3-vessel intravascular ultrasound (IVUS) data from the PROS-
PECT study to assess the prevalence, morphology, and clinical outcome of nonculprit plaque
ruptures in ACS patients. Among 660 patients, the prevalence of secondary, nonculprit plaque
rupture was 14.1%. These patients also had more high-risk plaque burden; a nonculprit lesion
with a plaque rupture was more often classiﬁed as a virtual histology-thin cap ﬁbroatheroma
(VH-TCFA) than a nonculprit lesion without a plaque rupture. Interestingly, the incidence of
overall major adverse cardiac events (MACE) did not differ signiﬁcantly between patients with
versus without a nonculprit plaque rupture.
Vici: Nonculprit lesions with a plaque rupture are not uncommon in patients with ACS. These
lesions show TCFA like features more often than plaques that have not ruptured. While we can
detect such multi focal ruptures, their importance remains less clear given that with current
therapies, these plaques did not seem to adversely inﬂuence the 3-year MACE rates.(continued on page A-10)
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A-10S T A T E - O F - T H E - A R T P A P E R406 The Role of Imaging in Aortic Dissection and Related SyndromesRagavendra R. Baliga, Christoph A. Nienaber, Eduardo Bossone, Jae K. Oh,
Eric M. Isselbacher, Udo Sechtem, Rossella Fattori, Subha V. Raman, Kim A. EagleI M A G I N G V I G N E T T E425 LV Outﬂow Tract Area in Discrete Subaortic Stenosis and Hypertrophic
Obstructive Cardiomyopathy: A Real-Time 3-Dimensional Transesophageal
Echocardiography Study
Hirotsugu Mihara, Kentaro Shibayama, Kenji Harada, Javier Berdejo,
Yuji Itabashi, Takahiro ShiotaL E T T E R S T O T H E E D I T O R429 Safety and Feasibility of Contrast Echocardiography for LVAD EvaluationNowell M. Fine, Sahar S. Abdelmoneim, Amy Dichak, Sudhir S. Kushwaha,
Soon J. Park, Sharon L. Mulvagh
430 Ex Vivo Cryoimaging for Plaque CharacterizationAli Faramarzalian, David Prabhu, Ahmad Abdul-Aziz, Wei Wang,
Daniel Chamie, Hirosada Yamamoto, Yusuke Fujino, Sami Hawwa, Nicholas P. Ziats,
Andrew M. Rollins, David L. Wilson, Marco A. Costa, Hiram G. Bezerra
432 In the Footsteps of VirchowHeinrich Taegtmeyer, Truong Lam
REPLYMinjie Lu, Shihua Zhao, Jing An(continued on page A-11)
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A-11E D I T O R ’ S P A G E434 Mentees, Mentors, and the Mentorship. . .Y. Chandrashekhar, Jagat NarulaI M A G I N G C O U N C I L C H A I R M A N ’ S P A G E438 Cardiovascular Imaging in the Pediatric PopulationMeryl S. Cohen, Neil J. WeissmanO N T H E C O V E RLead Location on 3D Echo and Tricuspid RegurgitationDevice lead locations on 3D transthoracic echocardiography: (Top) 3D zoom
examples of non-impinging leads. The device-leads are found in the posteroseptal
commissure (left), the anteroposterior commissure (middle) and in the center of the
valve (right). (Bottom) 3D zoom examples of impinging leads. From left-to-right
device-leads are found against the posterior leaﬂet, the septal leaﬂet and the anterior
leaﬂet. All these positions were associated with interference of leaﬂet motion. White
arrows point to the device-lead. Please see Mediratta et al. (page 337) for the related
article.
